Solution for Injection – Clear and colourless solution.
Therapeutic indications
• Suppression of ventricular extrasystoles and ventricular tachycardia, especially after an acute myocardial infarction.
•Local anaesthesia by surface infiltration, regional, epidural and caudal routes, dental anaesthesia, either alone or in combination with adrenaline.
• Lidocaine may also be administered by subcutaneous, intramuscular or intravenous injection.
• Not intended for use in the eye.
Qualitative and quantitative composition
• Each 1 ml contains 10.0 mg of lidocaine hydrochloride, corresponding to 8.1 mg lidocaine
•Each 2 ml solution contains 20 mg Lidocaine Hydrochloride E.P.
• Each 5 ml solution contains 50 mg Lidocaine Hydrochloride E.P.
• Each 10 ml solution contains 100 mg Lidocaine Hydrochloride E.P.
• Each 20 ml solution contains 200 mg Lidocaine Hydrochloride E.P.
• For the full list of excipients,
Features
Nature and contents of container
• Clear glass ampoule, glass type 1, E.P.
• Pack sizes 2,5,10 and 20ml ampoules. Batch size 10 ampoules per carton.
Special precautions for storage
• Store at less than 25°C.
• Protect from light.
